🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multi-center, 12-week, randomized, controlled, paral...
Status
Completed
Location
Please contact the Merck KGaA Communication Center
Start Date
2014-05-31
Trial ID
NCT02064816
The primary objective of the study was to evaluate the safe and effective u...
Status
Completed
Location
Research Site
Start Date
2009-01
Trial ID
NCT00828204
This is an international multicenter study of tolerability, pharmacokinetic...
Status
Completed
Location
OOO "BioEk"
Start Date
2014-07
Trial ID
NCT02359877
This is an observational study to assess the tolerability of Rebif treatmen...
Status
Completed
Location
Samsung Medical Center
Start Date
2008-08
Trial ID
NCT01074346
Treatments Being Tested
The purpose of this study is to find out if weekly Avonex works as well as ...
Status
Completed
Location
Research Site
Start Date
2002-08
Trial ID
NCT00599274
Treatments Being Tested
Phase I study aiming at: * establishing the pharmacokinetic profile of int...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT02517788
This is a Phase IV study to compare the current level of MS LifeLines ® (MS...
Status
Terminated
Location
Call EMD Serono Medical Information for information on recruiting sites
Start Date
2013-07
Trial ID
NCT01905527
Treatments Being Tested
Brief Summary: 800 RRMS Subjects currently treated with Avonex or Copaxone ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00101959
Treatments Being Tested
This is a 24-month, observational, prospective, multinational, multicenter ...
Status
Terminated
Location
Please contact the Merck KGaA Communication Center
Start Date
2015-02
Trial ID
NCT02394782
Treatments Being Tested
The purpose of this study is to determine whether ozanimod is effective in ...
Status
Completed
Location
Xenosciences Inc
Start Date
2014-12-03
Trial ID
NCT02294058
Treatments Being Tested